⏳ Final hours! Save up to 60% OFF InvestingProCLAIM SALE

Trulieve Cannabis' quarterly loss narrows on demand boost

Published 05/09/2024, 07:39 AM
Updated 05/09/2024, 11:35 AM
© Reuters. A thriving marijuana plant is seen at a grow operation in Denver, Colorado December 31, 2013.  REUTERS/Rick Wilking/File Photo
TCNNF
-

By Srivastava Vallari

(Reuters) -Pot firm Trulieve Cannabis (OTC:TCNNF) posted a narrower first-quarter loss on Thursday, driven by higher sales and robust demand.

The Florida-based company's net loss attributable to shareholders narrowed to $23.1 million in the quarter that ended March 31, down from $64.1 million a year earlier.

WHY IT'S IMPORTANT

Florida, with a population of more than 22 million, is a crucial medicinal marijuana market for Trulieve, which enjoys significant market share within the state.

Trulieve has been expanding its presence across the U.S. with plans to open 25 new stores in 2024 as it hopes to benefit from the potential legalization of the drug in Florida and at the Federal level.

CONTEXT

Last month, the U.S. Department of Justice moved to reclassify marijuana as a less dangerous drug, a step that will allow pot firms to deduct normal business expenses from their profit, thereby reducing the tax burden and boosting profitability.

Successful reclassification would also enable pot firms to uplist to major U.S. stock exchanges, improve banking and consumer access, and make medical research easier to conduct.

Earlier this year, the Florida Supreme Court had allowed voters to decide on the fate of recreational use of marijuana in the state through a referendum on the November ballot.

MARKET REACTION

Shares of the company rose 4.6% to C$15.55.

KEY QUOTES

"With strong performance in our core business and several meaningful catalysts on the horizon, the outlook has never been brighter," said CEO Kim Rivers.

"Given our financial performance and significant scale in key markets, Trulieve is best positioned for the coming wave of growth catalysts," she added.

ATB Capital Markets analysts said in a note that "...Trulieve has significant capital allocation optionality, positioning the company well for potential Florida adult-use legalization, or expansion in other markets."

BY THE NUMBERS

© Reuters. A thriving marijuana plant is seen at a grow operation in Denver, Colorado December 31, 2013.  REUTERS/Rick Wilking/File Photo

Trulieve posted revenue of $297.6 million in the first quarter, beating analysts' expectations of $285.9 million, according to LSEG data.

Loss from continuing operations narrowed to 16 cents per share in the January-March quarter, from 18 cents per share a year earlier.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.